Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
49.77
+1.19 (2.45%)
At close: Oct 16, 2025, 4:00 PM EDT
49.51
-0.26 (-0.52%)
After-hours: Oct 16, 2025, 7:37 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Apr '23 Apr '22 2012 - 2021
United States Revenue
1.00B1.01B
Log In
Log In
Log In
Upgrade
Japan Revenue
62.35M62.41M
Log In
Log In
Log In
Upgrade
Europe Revenue
169.31M175.66M
Log In
Log In
Log In
Upgrade
Asia Revenue
94.17M92.31M
Log In
Log In
Log In
Upgrade
Other Geographic Revenue
15.79M19.54M
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.35B1.36B
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Apr '23 Apr '22 2012 - 2021
Plasma Products and Services Revenue
--
Log In
Log In
Log In
Upgrade
Blood Center Products and Services Revenue
--
Log In
Log In
Log In
Upgrade
Hospital Products and Services Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Other)
1.35B1.36B
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.35B1.36B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Apr '23 Apr '22 2012 - 2021
Plasma Revenue
529.42M535.43M
Log In
Log In
Log In
Upgrade
Blood Center Revenue
246.72M261.12M
Log In
Log In
Log In
Upgrade
Hospital Revenue
569.91M564.27M
Log In
Log In
Log In
Upgrade
Service Revenue
--
Log In
Log In
Log In
Upgrade
Effect of Exchange Rates on Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Total)
1.35B1.36B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Apr '23 Apr '22 2012 - 2021
Plasma Segment Operating Income (Post-Q3 2025 Reporting)
-184.51M
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income (Post-Q3 2025 Reporting)
-52.82M
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income (Post-Q3 2025 Reporting)
-88.98M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
215.30M-104.49M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
215.30M221.82M
Log In
Log In
Log In
Upgrade

EBIT 2

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Apr '23 Apr '22 2012 - 2021
Plasma Segment Operating Income
--
Log In
Log In
Log In
Upgrade
Blood Center Segment Operating Income
--
Log In
Log In
Log In
Upgrade
Hospital Segment Operating Income
--
Log In
Log In
Log In
Upgrade
Operating Income (Total)
215.30M221.82M
Log In
Log In
Log In
Upgrade
Updated Aug 7, 2025. Data Source: Fiscal.ai.